DEEP Missions

We have a vision where pharma, academia, patient groups, technology providers and regulators collaborate pre-competitively to build regulatory-ready digital measures that can be shared and reused across drug development - to help improve the lives of patients. DEEP provides the platform, tools and services that make this kind of collaboration possible.

Browse the missions below - some are open for collaborators now, others are still being scoped. If you have one to propose, we would love to hear from you.

  • There are no suggestions because the search field is empty.

Defining New Digital Measures in Myasthenia Gravis

Developing precise and comprehensive digital measures for Myasthenia Gravis (MG) that capture meaningful aspects of the disease and address unmet needs in patient care and drug development.